Patents by Inventor Thilo Oelert

Thilo Oelert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11123368
    Abstract: The present invention refers to a method of producing immunosuppressive bleed cells that can be used for the treatment of autoimmune diseases, in particular multiple sclerosis, organ graft rejection and graft-versus-host disease.
    Type: Grant
    Filed: May 19, 2017
    Date of Patent: September 21, 2021
    Assignee: Universitatsklinikum Heidelberg
    Inventors: Peter Terness, Gerhard Opelz, Helmut Simon, Sandra Ehser, Christian Kleist, Flavius Sandra-Petrescu, Mircea Iancu, Lucian Jiga, Jing-Jing Chuang, Thilo Oelert
  • Publication number: 20170319619
    Abstract: The present invention refers to a method of producing immunosuppressive bleed cells that can be used for the treatment of autoimmune diseases, in particular multiple sclerosis, organ graft rejection and graft-versus-host disease.
    Type: Application
    Filed: May 19, 2017
    Publication date: November 9, 2017
    Applicant: Universitatsklinikum Heidelberg
    Inventors: Peter TERNESS, Gerhard OPELZ, Helmut SIMON, Sandra EHSER, Christian KLEIST, Flavius SANDRA-PETRESCU, Mircea IANCU, Lucian JIGA, Jing-Jing CHUANG, Thilo OELERT
  • Publication number: 20150132326
    Abstract: The present invention refers to a method of producing immunosuppressive blood cells that can be used for the treatment of autoimmune diseases, in particular multiple sclerosis, organ graft rejection and graft-versus-host disease.
    Type: Application
    Filed: November 7, 2014
    Publication date: May 14, 2015
    Applicant: Universitatsklinikum Heidelberg
    Inventors: Peter TERNESS, Gerhard OPELZ, Helmut SIMON, Sandra EHSER, Christian KLEIST, Flavius SANDRA-PETRESCU, Mircea IANCU, Lucian JIGA, Jing-Jing CHUANG, Thilo OELERT
  • Publication number: 20110223145
    Abstract: The present invention refers to a method of producing immunosuppressive blood cells that can be used for the treatment of autoimmune diseases, in particular multiple sclerosis, organ graft rejection and graft-versus-host disease.
    Type: Application
    Filed: June 30, 2009
    Publication date: September 15, 2011
    Inventors: Peter Terness, Gerhard Opelz, Helmut Simon, Sandra Ehser, Christian Kleist, Flavius Sandra-Petrescu, Mircea Iancu, Lucian Jiga, Jing-Jing Chuang, Thilo Oelert
  • Publication number: 20100087630
    Abstract: The invention relates to measuring immunological tolerance in T cells. In particular, the invention provides a method for measuring the tolerance status of a T cell sample, comprising the steps of (a) measuring the expression level of XCR1 (also known as GPR5, which is a receptor for Single C Motif-1/Lymphotactin) in a T cell sample, and (b) comparing the measured expression level with a reference value, said reference value being representative of the expression level of XCR1 in a control T cell sample. The present invention furthermore provides methods, kits and uses to determine the required stringency of immunosuppression, particularly the required dosage of an immunosuppressant. Also provided are methods and uses to identify or validate inducers or inhibitors of immunological tolerance.
    Type: Application
    Filed: February 27, 2006
    Publication date: April 8, 2010
    Applicant: Ruprecht-Karls-Universitat-Heidelberg
    Inventors: Thilo Oelert, Bernd Arnold, Guenter Haemmerling